These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 13637008)
1. Phenylindandione in therapy of coronary artery disease; study of its long-term use in ambulatory patients. TANDOWSKY RM Am J Cardiol; 1959 Apr; 3(4):551-3. PubMed ID: 13637008 [No Abstract] [Full Text] [Related]
2. [Phenylindanedione in the treatment of coronary artery disease. A study of its prolonged use in ambulatory patients]. TANDOWSKY RM Sem Med; 1960 Nov; 117():1697-9. PubMed ID: 13775173 [No Abstract] [Full Text] [Related]
3. Long-term anticoagulant therapy in coronary atherosclerosis. NICHOL ES; KEYES JN; BORG JF; COOGAN TJ; BOEHRER JJ; MULLINS WL; SCOTT T; PAGE R; GRIFFITH GC; MASSIE E Am Heart J; 1958 Jan; 55(1):142-52. PubMed ID: 13520562 [No Abstract] [Full Text] [Related]
4. Modern therapy of coronary artery disease. SPRAGUE HB Med Clin North Am; 1953 Sep; 1():1283-1301. PubMed ID: 13086020 [No Abstract] [Full Text] [Related]
6. Anticoagulants in coronary artery disease. DALEY R Proc R Soc Med; 1962 Aug; 55(8):695-7. PubMed ID: 13883202 [No Abstract] [Full Text] [Related]
7. [Treatment of coronary arteriosclerosis and coronary thrombosis]. GEILL T Nord Med; 1960 Jan; 63():133-7. PubMed ID: 13827129 [No Abstract] [Full Text] [Related]
8. Personal experiences with anticoagulants for coronary atherosclerosis. NICHOL ES Circulation; 1959 Jan; 19(1):129-34. PubMed ID: 13619034 [No Abstract] [Full Text] [Related]
9. [Influence of therapy on the development of obstructive coronary arteriosclerosis]. FROMENT R; LENEGRE J; GONIN A; PERRIN A; HIMBERT J; NORMAND J; DELAHAYE JP Sem Hop; 1961 Dec; 37():3343-7. PubMed ID: 13895491 [No Abstract] [Full Text] [Related]
10. [Influence of therapy on the evolution of obstructive coronary atherosclerosis]. FROMENT R; LENEGRE J; GONIN A; PERRIN A; HIMBERT J; NORMAND J; DELAHAYE JP Sem Hop Ther Paris; 1962 Feb; 38():101-5. PubMed ID: 13895492 [No Abstract] [Full Text] [Related]
11. [Effects of iproniazid in coronary arteriosclerosis]. LOPEZ ED; RESSIA TP; SUAREZ JA; ZIPEROVICH S Sem Med; 1960 Aug; 117():400-1. PubMed ID: 13763442 [No Abstract] [Full Text] [Related]
12. The cholesterol lowering effects of triparanol (MER-29) in subjects with and without coronary artery disease. HOLLANDER W; CHOBANIAN AV; WILKINS RW Prog Cardiovasc Dis; 1960 May; 2():637-44. PubMed ID: 13852510 [No Abstract] [Full Text] [Related]
13. The effect of volatile 1-cyclohexyl-2-methylaminopropane ("Benzedrex" inhaler) on patients with coronary arteriosclerosis. Burnett JB; Gundersen SM N Engl J Med; 1952 Mar; 246(12):449-50. PubMed ID: 14910836 [No Abstract] [Full Text] [Related]
14. The ambulatory treatment of coronary disease with anticoagulants. JOLLY AT Med J Aust; 1956 Apr; 43(15):609-16. PubMed ID: 13321202 [No Abstract] [Full Text] [Related]
15. Long-term anticoagulant therapy for coronary thrombosis. TOOHEY M Br Med J; 1958 Aug; 2(5094):473-5. PubMed ID: 13560904 [No Abstract] [Full Text] [Related]
16. Long-term anticoagulant therapy in coronary disease. ENSOR RE; PETERS HR J Am Med Assoc; 1959 Feb; 169(9):914-8. PubMed ID: 13630704 [No Abstract] [Full Text] [Related]